The Invesco Dow Jones Industrial Average Dividend ETF (DJD) is a passively managed fund that tracks the Dow Jones Industrial Average Yield Weighted Index. Unlike the traditional, price-weighted Dow Jones Industrial Average, this benchmark selects the dividend-paying members of the Dow and weights them according to their indicated annual dividend yield. The result is a portfolio tilted toward higher-yielding blue-chip names, with only constituents that maintain a dividend qualifying for inclusion.
The fund is concentrated, holding roughly 29 to 30 securities, and is classified as non-diversified. Its expense ratio is a low 0.07%, making it a cost-efficient vehicle for income-oriented large-cap exposure. Top holdings have historically included NKE, PG, CVX, HD, MCD, IBM, AMGN, KO, UNH, and MRK. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Sector allocation skews toward healthcare, consumer discretionary, consumer staples, financials, and information technology, with meaningful but smaller energy and industrials exposure. Because the fund is 100% U.S. equity and weights holdings by yield rather than market capitalization, its future performance is driven less by broad market breadth and more by the dividend durability, earnings power, and payout growth of a compact group of mature, cash-generative companies.
The macro outlook is central to this ETF forecast. If the Federal Reserve proceeds with rate cuts and bond yields drift lower, dividend-yielding large caps tend to look more attractive relative to cash and short-duration fixed income, potentially supporting valuations. Conversely, an extended higher-for-longer rate environment could keep a lid on multiple expansion for slower-growth, income-heavy companies.
The portfolio's healthcare weighting, historically one of the largest sector exposures, links the fund to demographic tailwinds such as an aging population and sustained demand for pharmaceuticals and managed care. At the same time, this sector faces policy and regulatory scrutiny that could resurface as a headwind. The consumer staples and defensive tilt provides relative earnings stability during economic slowdowns, while the financials and energy sleeve adds cyclicality and commodity sensitivity.
Because the ETF is yield-weighted, its sector exposure can shift meaningfully at each rebalance as dividend yields and constituent prices change. This structural feature means the fund's future sector outlook is dynamic rather than fixed, making ongoing monitoring of the index's composition an important part of assessing its trajectory.
Over the long term, this ETF's structural positioning is anchored in the enduring appeal of mature, dividend-paying U.S. large caps. Demographic shifts, including an aging population, support sustained demand for healthcare products and services, while global brand franchises in consumer staples and discretionary sectors provide recurring revenue streams. The emphasis on companies with established payout histories aligns the fund with income-seeking investors as retirement-oriented capital continues to grow.
The fund's yield-weighting methodology is itself a structural differentiator. By favoring higher-yielding constituents, it tilts exposure toward value-oriented and defensive segments of the Dow rather than growth-heavy names. This can provide relative stability in risk-off environments but may lag in periods dominated by high-growth technology leadership. As the interest rate cycle matures and market breadth broadens or narrows, the fund's dividend-weighted, non-diversified construction will remain the key determinant of its long-term risk and return profile.
In my analysis of funds like this one, I often turn to Tickeron’s Trend Prediction Engine to get AI-driven forecasts on potential bullish, bearish, or sideways moves. It helps spot developing trends and offers historical context that complements fundamental research. From what I see, layering these predictions onto the ETF’s macro and sector drivers provides an additional data point for timing decisions without replacing core due diligence.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where DJD declined for three days, in 211 of 300 cases, the price declined further within the following month. The odds of a continued downward trend are 70%.
The 10-day RSI Indicator for DJD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 32 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 69 cases where DJD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 67%.
The Moving Average Convergence Divergence Histogram (MACD) for DJD turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 34 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.
DJD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on DJD as a result. In 72 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
DJD moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for DJD crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Following a +1.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where DJD advanced for three days, in 265 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 251 of 325 cases where DJD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows